Karki Reeba, Marasini Anupama, Mahaseth Rajeev Kumar, Bista Ranishma, Dongol Suman Raj, Adhikari Yuvraj
Department of ENT-HNS, Shree Birendra Hospital, Kathmandu, Nepal.
Ann Med Surg (Lond). 2024 Mar 6;86(5):2503-2506. doi: 10.1097/MS9.0000000000001918. eCollection 2024 May.
Head and neck cancer is common in several parts of the world. It is sixth most prevalent neoplasms in the world. Approximately 900 000 cases diagnosed worldwide per year. It has good prognosis when timely diagnosed and treated appropriately.
This was a retrospective study carried out in the Department of ENT-HNS of Shree Birendra Hospital, Chhauni, Kathmandu from May 2022 to April 2023. All histopathologically proven malignant cases of head and neck region were included in the study. Data were entered in Microsoft excel and managed in SPSS version 22. Analysis was done in the form of percentage and proportion and represented as table where necessary. The study has been registerd in clinical trials and has been reported in line with the STROCSS criteria.
Total 76 patients were analyzed. Age ranged from 17 to 84 years and the most common age group presenting with head and neck cancer was 61-80 years. The most common malignancy was laryngeal cancer (34%) followed by thyroid malignancies (29%). Squamous cell carcinoma was the commonest histological type (48%). Surgery with postoperative radiotherapy (RT)/radioactive iodine (RAI) was found to be the commonest treatment modality.
Head and neck cancers are not uncommon and majority of patients present late with advanced stage cancer. Hence, public awareness, early diagnosis with cost-effective treatment and regular follow-up are needed to improve outcomes of these patients in our society.
头颈癌在世界上的多个地区都很常见。它是全球第六大最常见的肿瘤。每年全球约有90万例确诊病例。如果能及时诊断并得到适当治疗，其预后良好。
这是一项回顾性研究，于2022年5月至2023年4月在加德满都Chhauni的Shree Birendra医院耳鼻喉 - 头颈外科进行。所有经组织病理学证实的头颈区域恶性病例均纳入本研究。数据录入Microsoft excel并在SPSS 22版中进行管理。分析以百分比和比例的形式进行，并在必要时以表格形式呈现。该研究已在临床试验中注册，并已按照STROCSS标准进行报告。
共分析了76例患者。年龄范围为17至84岁，头颈癌最常见的年龄组为61 - 80岁。最常见的恶性肿瘤是喉癌（34%），其次是甲状腺恶性肿瘤（29%）。鳞状细胞癌是最常见的组织学类型（48%）。手术加术后放疗（RT）/放射性碘（RAI）被发现是最常见的治疗方式。
头颈癌并不罕见，大多数患者就诊时已处于癌症晚期。因此，需要提高公众意识，进行具有成本效益的早期诊断和定期随访，以改善我们社会中这些患者的治疗效果。
